M Franchini, G Marano, M Cruciani, C Mengoli, I Pati… - Diagnosis, 2020 - degruyter.com
Abstract Coronavirus disease 2019 (COVID-19), a viral respiratory illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been recently …
A Allegra, V Innao, AG Allegra, C Musolino - Annals of hematology, 2020 - Springer
In October 2019, a viral infectious disease appeared in the city of Wuhan in China. A new betacoronavirus, SARS-CoV-2, has been recognized as the responsible pathogen in this …
In critically ill patients with acute respiratory distress syndrome (ARDS) coronavirus disease 2019 (COVID-19), a high incidence of thromboembolic and hemorrhagic events is reported …
G Kasinathan, J Sathar - Annals of medicine and surgery, 2020 - Elsevier
Abstract Coronavirus-19 disease (COVID-19), a zoonosis, was first reported in the city of Wuhan, province of Hubei, China in December 2019. The disease is caused by the Severe …
W Miesbach, M Makris - Clinical and applied thrombosis …, 2020 - journals.sagepub.com
The novel coronavirus infection (COVID-19) is caused by the new coronavirus SARS-CoV-2 and is characterized by an exaggerated inflammatory response that can lead to severe …
T Iba, JH Levy, M Levi, J Thachil - Journal of thrombosis and haemostasis, 2020 - Elsevier
The COVID‐19 pandemic has become an urgent issue in every country. Based on recent reports, the most severely ill patients present with coagulopathy, and disseminated …
M Kohansal Vajari, M Shirin… - Cell biology …, 2021 - Wiley Online Library
December 2019 will never be forgotten in the history of medicine when an outbreak of pneumonia of unknown etiology in Wuhan, China sooner or later prompted the World Health …
SG Lee, M Fralick, M Sholzberg - CMAJ, 2020 - Can Med Assoc
Coagulopathy correlates with severity of COVID-19 and may include increased d-dimer concentrations (≥ 2 times above normal range), mildly prolonged prothrombin time (~ 1–3 s …